Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)

ClinicalTrials.gov ID: NCT04626596

Public ClinicalTrials.gov record NCT04626596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to assess the efficacy and safety of the etonogestrel (ENG) contraceptive implant during participants' fourth and fifth years of use when used as the only method of contraception. The ENG implant is currently approved for a 3-year duration, and this study aims to confirm available evidence suggesting that the ENG implant remains highly effective when used up to 5 years.

Study identification

NCT ID
NCT04626596
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
498 participants

Conditions and interventions

Conditions

Interventions

Combination Product

Eligibility (public fields only)

Age range
Up to 35 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2020
Primary completion
Dec 29, 2024
Completion
Dec 29, 2024
Last update posted
Feb 17, 2026

2020 – 2024

United States locations

U.S. sites
64
U.S. states
32
U.S. cities
52
Facility City State ZIP Site status
Alabama Clinical Therapeutics (Site 0222) Birmingham Alabama 35205
Desert Star Family Planning (Site 0193) Phoenix Arizona 85015
Precision Trials (Site 0187) Phoenix Arizona 85032
Visions Clinical Research Tucson (Site 0134) Tucson Arizona 85712
Essential Access Health (Site 0163) Los Angeles California 90010
Matrix Clinical Research Inc (Site 0105) Los Angeles California 90057
University of California Los Angeles (Site 0119) Los Angeles California 90095
University of California, Davis (Site 0124) Sacramento California 95817
Stanford University (Site 0112) Stanford California 94305
Planned Parenthood of the Rocky Mountains (Site 0196) Denver Colorado 80207
Comprehensive Womens Health Center (Site 0194) Denver Colorado 80230
Physicians' Research Options, LLC (Site 0166) Lakewood Colorado 80228
University Of Florida (Site 0144) Jacksonville Florida 32207
Emerald Coast Obstetrics and Gynecology (Site 0203) Panama City Florida 32405
Lenus Research & Medical Group Llc (Site 0102) Sweetwater Florida 33172
Comprehensive Clinical Trials LLC (Site 0101) West Palm Beach Florida 33409
Mount Vernon Clinical Research (Site 0111) Sandy Springs Georgia 30328
Rosemark (Site 0177) Idaho Falls Idaho 83404
Planned Parenthood of Illinois (PPIL) (Site 0200) Chicago Illinois 60610
Indiana University (Site 0220) Indianapolis Indiana 46202
McFarland Clinic, PC (Site 0217) Ames Iowa 50010-3014
Cypress Medical Research Center (Site 0226) Wichita Kansas 67226
Southern Clinical Research Associates (Site 0219) Metairie Louisiana 70001
Johns Hopkins Bayview Medical Center (Site 0225) Baltimore Maryland 21224
Boston University Medical Center (Site 0167) Boston Massachusetts 02118
Planned Parenthood League of Massachusetts (Site 0135) Boston Massachusetts 02215
Michigan Medicine (Site 0108) Ann Arbor Michigan 48109
Saginaw Valley Medical Research Group, LLC (Site 0198) Saginaw Michigan 48604
Planned Parenthood of North Central States (PPNCS) (Site 0113) Minneapolis Minnesota 55408
Metro Jackson OBGYN/SKYCRNG (Site 0233) Jackson Mississippi 39202
Planned Parenthood of the Saint Louis Region & Southwest Missouri (Site 0158) St Louis Missouri 63108
Washington University (Site 0129) St Louis Missouri 63108
Office of Edmond Pack, MD (Site 0168) Las Vegas Nevada 89113
Capital Health OB/GYN- Lawrenceville (Site 0190) Lawrenceville New Jersey 08648
Albuquerque Clinical Trials (Site 0210) Albuquerque New Mexico 87102
Bosque Women's Care (Site 0211) Albuquerque New Mexico 87111
Icahn School of Medicine at Mount Sinai (Site 0155) New York New York 10029
Columbia Univ. Medical Center (Site 0118) New York New York 10032
Montefiore Medical Center (Site 0103) The Bronx New York 10461
Carolina Women's Research and Wellness Center (Site 0154) Durham North Carolina 27713
Eastern Carolina Women's Center (Site 0159) New Bern North Carolina 28562
Velocity Clinical Research, Cincinnati (Site 0230) Cincinnati Ohio 45242
The Ohio State University (Site 0176) Columbus Ohio 43210
HWC Women's Research Center (Site 0199) Englewood Ohio 45322
Oregon Health Sciences University Hospital (Site 0128) Portland Oregon 97239
OB/GYN Associates of Erie (Site 0183) Erie Pennsylvania 16507
University of Pittsburgh - Magee Womens Hospital (Site 0100) Pittsburgh Pennsylvania 15213
Palmetto Clinical Research (Site 0133) Summerville South Carolina 29485
University of Tennessee Medical Center Knoxville (Site 0218) Knoxville Tennessee 37920
Gadolin Research (Site 0232) Beaumont Texas 77702
Signature Gyn Services (Site 0201) Fort Worth Texas 76104
Planned Parenthood of the Gulf Coast (Site 0106) Houston Texas 77023
University of Texas Health Science Center (Site 0178) Houston Texas 77030
Centex Studies, Inc. (Site 0171) Houston Texas 77058
Advances in Health, Inc. (Site 0209) Pearland Texas 77030
Tekton Research - Floyd Curl Drive (Site 0228) San Antonio Texas 78229
Physicians' Research Options, LLC (Site 0204) Pleasant Grove Utah 84062
JBR Clinical Research (Site 0174) Salt Lake City Utah 84107
Tidewater Clinical Research Inc (Site 0162) Norfolk Virginia 23502
Eastern Virginia Medical School (Site 0146) Norfolk Virginia 23507
Multicare Health System Institute for Research and Innovation (Site 0188) Cheney Washington 99004
Seattle Women's: Health, Research, Gynecology (Site 0149) Seattle Washington 98105
Planned Parenthood Great Northwest, Hawai'i, Alaska, Indiana, Kentucky (Site 0110) Seattle Washington 98122
North Spokane Women's Clinic (Site 0137) Spokane Washington 99207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04626596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 17, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04626596 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →